Esophageal tolerance to high-dose stereotactic ablative radiotherapy

Diseases of the Esophagus

Volumn 25, Issue 7, 2012, Pages 623-629

  Abelson, J A ^a   Murphy, J D ^a   Loo Jr, B W ^a   Chang, D T ^a   Daly, M E ^a   Wiegner, E A ^a   Hancock, S ^a   Chang, S D ^a   Le, Q T ^a   Soltys, S G ^a   Gibbs, I C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Esophagus; Hypofractionation; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy; Toxicity

Indexed keywords

CARBOPLATIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSIMETRY; ESOPHAGITIS; ESOPHAGUS PERFORATION; FEMALE; HEMOPTYSIS; HUMAN; LUNG TUMOR; MALE; MEDIASTINITIS; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; SPINE TUMOR; STEREOTACTIC BODY RADIATION THERAPY; TRACHEOESOPHAGEAL FISTULA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL PERFORATION; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; TIME FACTORS; TRACHEOESOPHAGEAL FISTULA;

EID: 84866292846     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01295.x     Document Type: Article

References (27)

1. Timmerman R, Paulus R, Galvin J etal. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-6.
2. Yamada Y, Bilsky M H, Lovelock D M etal. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 2008; 71: 484-90.
3. Fakiris A J, McGarry R C, Yiannoutsos C T etal. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009; 75: 677-82.
4. Timmerman R, McGarry R, Yiannoutsos C etal. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-9.
5. Barnes M, Pass H, DeLuca A etal. Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy (IORT). Int J Radiat Oncol Biol Phys 1987; 13: 371-8.
6. de Boer W J, Mehta D M, Timens W, Hoekstra H J. The short and long term effects of intraoperative electron beam radiotherapy (IORT) on thoracic organs after pneumonectomy: an experimental study in the canine model. Int J Radiat Oncol Biol Phys 1999; 45: 501-6.
7. Sindelar W F, Hoekstra H J, Kinsella T J etal. Response of canine esophagus to intraoperative electron beam radiotherapy. Int J Radiat Oncol Biol Phys 1988; 15: 663-9.
8. Gomez D R, Hunt M A, Jackson A etal. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 2009; 93: 414-8.
9. Le Q T, Loo B W, Ho A etal. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006; 1: 802-9.
10. Onimaru R, Shirato H, Shimizu S etal. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003; 56: 126-35.
11. Onishi H, Shirato H, Nagata Y etal. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007; 2 (Suppl 3): S94-100.
12. Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177: 645-55.
13. Timmerman R D. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008; 18: 215-22.
14. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. 2009.
15. Kaplan E L, Meier, P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. Brenner D J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008; 18: 234-9.
17. Kirkpatrick J P, Meyer J J, Marks L B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008; 18: 240-3.
18. Park C, Papiez L, Zhang S, Story M, Timmerman R D. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 847-52.
19. Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks L B. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010; 76 (Suppl): S86-93.
20. Emami B, Lyman J, Brown A etal. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
21. Poltinnikov I M, Fallon K, Xiao Y, Reiff J E, Curran W J Jr, Werner-Wasik M. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 62: 652-8.
22. Rose J, Rodrigues G, Yaremko B, Lock M, D'Souza D. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 2009; 91: 282-7.
23. Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran W. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 2000; 48: 689-96.
24. Dieleman E M, Senan S, Vincent A, Lagerwaard F J, Slotman B J, de Koste J R. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys 2007; 67: 775-80.
25. Hashimoto T, Shirato H, Kato M etal. Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J Radiat Oncol Biol Phys 2005; 61: 1559-64.
26. Weiss E, Wijesooriya K, Dill S V, Keall P J. Tumor and normal tissue motion in the thorax during respiration: analysis of volumetric and positional variations using 4D CT. Int J Radiat Oncol Biol Phys 2007; 67: 296-307.
27. Weiss E, Wijesooriya K, Keall P. Esophagus and spinal cord motion relative to GTV motion in four-dimensional CTs of lung cancer patients. Radiother Oncol 2008; 87: 44-8.